Literature DB >> 15200661

A case of severe diazoxide toxicity.

Paolo Silvani1, Anna Camporesi, Anna Mandelli, Andrea Wolfler, Ida Salvo.   

Abstract

Hyperinsulism is a rare cause of persistent hypoglycemia in the neonatal period. Therapy can be accomplished either surgically or pharmacologically. Diazoxide treatment remains the mainstay of medical therapy. Tolerance of diazoxide is usually excellent, but several adverse effects of this drug have been described. A case of severe diazoxide intoxication with fluid retention, congestive heart failure, and respiratory failure is reported. The patient was a 43-day-old infant, affected by persistent and severe hypoglycemia. After the diagnosis, hyperinsulinism was established he was treated with diazoxide (17 mg x kg(-1) daily) and octreotide (12 microg x kg(-1) daily). A few days later he presented with hepatomegaly, severe fluid retention, diffuse edema, congestive heart failure, and respiratory failure requiring mechanical ventilation. After introduction of ACE inhibitors he developed acute renal failure. The clinical condition worsened and he developed pulmonary hypertension requiring high-frequency oscillatory ventilation. Diazoxide was stopped on the 12th day in spite of poor control of blood sugar. During the next 5 days his hemodynamic status dramatically improved and he was weaned from catecholamines: he lost weight, had a negative fluid balance, and the edema disappeared, a normal diuresis resumed and renal function improved. Improvement of respiratory patterns and gas exchange made it possible to switch back to conventional ventilation and then to extubate the patient. Echocardiography demonstrated reduction of the PA pressure to normal and resolution of atrial enlargement. The patient was scheduled for elective subtotal pancreatectomy. Diagnosis and management of diazoxide intoxication are discussed. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200661     DOI: 10.1111/j.1460-9592.2004.01276.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  11 in total

1.  Echocardiography monitoring for diazoxide induced pericardial effusion.

Authors:  Bindu Avatapalle; Indraneel Banerjee; Nilima Malaiya; Raja Padidela
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo.

Authors:  G de J García-Rivas; K Carvajal; F Correa; C Zazueta
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

Review 3.  The management of hypertensive emergencies in children after stem cell transplantation.

Authors:  D G Horn; M N Trame; G Hempel
Journal:  Int J Clin Pharm       Date:  2011-03-12

Review 4.  Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.

Authors:  Matthew R Timlin; Alexander B Black; Heather M Delaney; Renée I Matos; Candace S Percival
Journal:  Pediatr Cardiol       Date:  2017-06-22       Impact factor: 1.655

5.  Diazoxide-Induced Neutropenia and Long-Term Follow-up in a Patient with Hyperinsulinemia-Hyperammonemia due to GLUD1 Mutation.

Authors:  D Vuralli; S Aytac Eyupoglu; N Kandemir; A Ozon; N Gonc; A Alikasifoglu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

6.  Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.

Authors:  Adriana Herrera; Mary Ellen Vajravelu; Stephanie Givler; Lauren Mitteer; Catherine M Avitabile; Katherine Lord; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

7.  Frequency and etiology of persistent neonatal hypoglycemia using the more stringent 2015 Pediatric Endocrine Society hypoglycemia guidelines.

Authors:  Rozeanna Skovrlj; Seth D Marks; Celia Rodd
Journal:  Paediatr Child Health       Date:  2018-12-22       Impact factor: 2.253

8.  A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.

Authors:  Maria Jesus Del Cerro; Steven Abman; Gabriel Diaz; Alexandra Heath Freudenthal; Franz Freudenthal; S Harikrishnan; Sheila G Haworth; Dunbar Ivy; Antonio A Lopes; J Usha Raj; Julio Sandoval; Kurt Stenmark; Ian Adatia
Journal:  Pulm Circ       Date:  2011       Impact factor: 3.017

9.  Prevalence and safety of diazoxide in the neonatal intensive care unit.

Authors:  Keyaria D Gray; Kathryn Dudash; Carla Escobar; Colman Freel; Tylah Harrison; Chandler McMillan; Mihai Puia-Dumitrescu; C Michael Cotten; Robert Benjamin; Reese H Clark; Daniel K Benjamin; Rachel G Greenberg
Journal:  J Perinatol       Date:  2018-09-11       Impact factor: 3.225

10.  Diazoxide Causality Assessment of a Pericardial Effusion in a Child with Kabuki Syndrome

Authors:  Irene Maffre; Marie Vincenti; Fabienne Dalla Vale; Cyril Amouroux; Oscar Werner; Alexandra Meilhac; Gaelle de Barry; Pascal Amedro
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.